Investors

Press Releases

Date Title View
Toggle Summary Tetraphase Pharmaceuticals President & CEO Guy Macdonald to Present at 2011 BIO International Convention
Tetraphase Pharmaceuticals President & CEO Guy Macdonald to Present at 2011 BIO International Convention Tetraphase Pharmaceuticals President & CEO Guy Macdonald to Present at 2011 BIO International Convention Watertown, MA – June 23, 2011 – Tetraphase Pharmaceuticals, Inc., a
View HTML
Toggle Summary Tetraphase Presents Data Demonstrating Robust Activity and Dosing Flexibility of Intravenous and Oral Next-Generation Antibiotic Candidates Targeting Complicated, Multidrug-Resistant Pathogens
– Presentations at the 21st ECCMID Highlight Activity of TP-434 in Both I.V. and Oral Step-Down Therapies and Potency and Oral Activity of TP-2758 Against Multidrug-Resistant Gram-Negative Pathogens –
View HTML
Toggle Summary Tetraphase to Present at Cambridge Health Institute's Antibacterial Drug Development Conference
– Company to Provide Insights on ‘Targeting Pathogens Resistant to Current Antibiotics’ Applauds WHO for Focus on Antimicrobial Resistance on World Health Day 2011 –
View HTML
Toggle Summary Tetraphase to Present at 10th Annual Needham Healthcare Conference
Tetraphase to Present at 10th Annual Needham Healthcare Conference Watertown, MA – March 30, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant
View HTML
Toggle Summary Tetraphase to Present at Cowen and Company 31st Annual Health Care Conference
31st Annual Health Care Conference
View HTML
Toggle Summary Tetraphase to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Tetraphase to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference Watertown, MA – February 10, 2011 – Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to
View HTML
Toggle Summary Tetraphase Appoints Patrick Horn, M.D., Ph.D., As Chief Medical Officer
- In New Role, Horn Will Direct Clinical Development of Tetraphase’s Potent Antibiotic Product Portfolio -
View HTML
Toggle Summary Tetraphase Announces Presentation at Lazard Capital Markets and Piper Jaffray & Co. Healthcare Conferences
Tetraphase Announces Presentation at Lazard Capital Markets and Piper Jaffray & Co. Healthcare Conferences Tetraphase Announces Presentation at Lazard Capital Markets and Piper Jaffray & Co. Healthcare Conferences Watertown, MA – November 11, 2010 – Tetraphase Pharmaceuticals, Inc., a
View HTML
Toggle Summary Tetraphase Pharmaceuticals Names Garen Bohlin to Board of Directors to Advance Strategic Interests and Broaden Corporate Development Goals
– Bohlin to provide strategic leadership to optimally leverage the company’s full range of corporate development opportunities –
View HTML
Toggle Summary Tetraphase Announces Presentation at BIO Investor Forum and Panel Discussion at Citi's 5th Annual Biotech Day
Tetraphase Announces Presentation at BIO Investor Forum and Panel Discussion at Citi's 5th Annual Biotech Day Tetraphase Announces Presentation at BIO Investor Forum and Panel Discussion at Citi's 5th Annual Biotech Day Watertown, MA – October 1, 2010 –Tetraphase Pharmaceuticals, Inc.,
View HTML